Eden vs Found: Which GLP-1 Provider Fits Your Plan? — 2026 Verified

Last reviewed: September 1, 2026 Last updated: September 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

If you want month-to-month flexibility and the lowest entry cost, Eden delivers injectable semaglutide at $198/month and tirzepatide at $298/month (medication plus mandatory membership, verified September 2026). Found's month-to-month cash rates run higher—$289 semaglutide, $359 tirzepatide—but drop to per-month figures of $169 and $239 on a 12-month prepaid plan (billed every 48 weeks). Found also accepts insurance for eligible members, starting at $99–$199/month depending on coverage. PlexusDx month-to-month injectable semaglutide costs $189 and tirzepatide $289, with lower committed-term rates and additional format options including oral capsules and a microdose protocol. All three use compounded medications; none offer FDA-approved branded GLP-1s at these prices. If you're certain you'll stay on treatment for a year, Found's 12-month prepaid cash plan and PlexusDx's 6-month prepaid plan both undercut Eden's annual total. If you're testing tolerance or prefer month-to-month control, Eden's $198 semaglutide beats Found's $289 month-to-month but trails PlexusDx's $189.

At-a-glance: Eden, Found, and PlexusDx

Pricing normalized: 12-month cost calculations

Eden bills calendar-monthly (12 charges per year). Found's month-to-month cash plan bills every 4 weeks, producing 13 charges annually. PlexusDx bills calendar-monthly. All figures below are our calculations using standard ongoing rates and prepaid totals only, verified at the dates shown.

Semaglutide injection – month-to-month 12-month total

Tirzepatide injection – month-to-month 12-month total

Prepaid multi-month plans—semaglutide: Found's 12-month prepaid cash plan costs a per-month figure of $169 (total $2,197 every 48 weeks, our calculation: 13 × $169). PlexusDx's 6-month prepaid plan costs a per-month figure of $149 (total $894 every 6 months). Over 12 months, PlexusDx 6-month prepaid totals $1,788 (our calculation: 2 × $894), Found 12-month prepaid totals $2,197, and Eden (monthly-only) totals $2,376.

Prepaid multi-month plans—tirzepatide: Found's 12-month prepaid cash plan costs a per-month figure of $239 (total $3,107 every 48 weeks, our calculation: 13 × $239). PlexusDx's 6-month prepaid plan costs a per-month figure of $249 (total $1,494 every 6 months). Over 12 months, PlexusDx 6-month prepaid totals $2,988 (our calculation: 2 × $1,494), Found 12-month prepaid totals $3,107, and Eden (monthly-only) totals $3,576.

Decision factors: what the evidence shows

Eden's strengths

Eden's $198 semaglutide month-to-month undercuts Found's $289 cash MTM by $91 per month and beats PlexusDx's $189 by only $9 per month. The mandatory $99/month membership is built into every monthly charge, so there's no separate recurring fee to track. Eden offers a "Lose 10% in 6 months or get your money back" pledge on compounded plans (full terms not captured in our sources, so confirm conditions at checkout). Monthly-only billing means you can cancel anytime without forfeiting prepaid charges. For members who want injectable-only options and predictable month-to-month costs, Eden delivers a competitive entry price on semaglutide and tirzepatide.

Eden's gaps

Eden publishes no committed-term rates; you pay the same $198 or $298 whether you stay one month or twelve. Over a year, Eden's semaglutide totals $2,376—higher than PlexusDx's 6-month prepaid annual total of $1,788 and Found's 12-month prepaid total of $2,197. The two-charge billing structure (medication + membership) is transparent but adds a line item. Eden's captured sources mention injectable formats only; no oral capsules or microdose protocols appeared in the September 2026 snapshots. If you're certain you'll commit for six months or longer, prepaid plans from Found or PlexusDx deliver lower total costs.

Found's strengths

Found's 12-month prepaid cash plan brings semaglutide to a per-month figure of $169 and tirzepatide to a per-month figure of $239—the lowest per-month rates in this comparison when you prepay for 48 weeks. Found accepts insurance for eligible members (in-network for 1 in 3 Americans, starting at $99–$199/month depending on plan length and coverage; copays may apply). Every cash plan includes the Found app, 24/7 access to the care team, and an AI health companion. Found grants a full refund if you're not clinically eligible and you can cancel anytime in the app. The tiered cash structure (MTM, 3-month, 6-month, 12-month) gives committed users a clear path to lower rates.

Found's gaps

Found's month-to-month cash rates are the highest in this comparison: $289 semaglutide and $359 tirzepatide produce 12-month totals of $3,757 and $4,667 (our calculations, 13 charges per year). The every-4-weeks billing cadence means 13 charges annually instead of 12, inflating the annual cost compared to calendar-month providers. The 12-month prepaid plan locks you into 48 weeks of charges upfront; if you discontinue early, confirm refund terms before purchasing. Found's insurance track advertises $99–$199/month, but price varies by medication, coverage, and potential copays—making it harder to predict your out-of-pocket total without submitting eligibility. The captured sources list additional medications (Ozempic, Wegovy, Zepbound, Mounjaro, Saxenda, Victoza, Metformin, Foundayo, and microdosing) but publish no cash pricing for those options, so you must contact Found for quotes.

PlexusDx's strengths

PlexusDx month-to-month injectable semaglutide costs $189—$9 below Eden and $100 below Found's cash MTM—with calendar-month billing (12 charges per year). The 6-month prepaid plan drops semaglutide to a per-month figure of $149 and tirzepatide to a per-month figure of $249, producing 12-month totals of $1,788 and $2,988 (our calculations)—the lowest annual costs in this comparison. PlexusDx offers oral capsules (semaglutide $289 MTM, tirzepatide $349 MTM) and a microdose GLP-1 protocol ($129 MTM) for members who prefer non-injectable formats or maintenance dosing. One all-inclusive charge covers the provider visit, prescription, compounded medication, and shipping; no separate membership fee. An optional genetic testing add-on ($298 standalone, $99 for program members) is available, though the test does not select or predict your medication—your provider decides. Free Doctor of Pharmacy check-ins are included. You can cancel anytime on month-to-month; 3- and 6-month rates are prepaid.

PlexusDx's gaps

PlexusDx does not accept insurance for medication (HSA/FSA eligible). The 6-month prepaid plan requires paying $894 or $1,494 upfront (semaglutide or tirzepatide), which may exceed some budgets despite the lower per-month figure. PlexusDx publishes no 12-month prepaid option, so users seeking the longest commitment tier must choose Found's 12-month plan or stick with PlexusDx's 6-month cycles. The oral capsule prices ($289 semaglutide, $349 tirzepatide MTM) exceed injectable MTM rates and rival Found's injectable MTM cash rates, making oral a premium rather than budget choice.

Choose Eden if…

• You want month-to-month flexibility with no long-term commitment and a competitive semaglutide price ($198) or tirzepatide price ($298).
• You value a money-back weight-loss pledge (confirm full terms at checkout).
• You prefer injectable formats and don't need oral capsules or microdose protocols.
• You're comfortable with a two-charge billing structure (medication + membership).
• You're testing GLP-1 tolerance and want the option to cancel after one month without forfeiting prepaid charges.

Choose Found if…

• You can commit to a 12-month prepaid plan and want the lowest per-month rates ($169 semaglutide, $239 tirzepatide).
• You have insurance coverage and want to explore the $99–$199/month insurance track (confirm copays and eligibility before enrolling).
• You value integrated support tools—24/7 care team access, the Found app, and an AI health companion—in one plan price.
• You're willing to navigate the every-4-weeks billing cadence on month-to-month plans (13 charges per year).
• You want access to a broader medication menu (branded GLP-1s, metformin, Foundayo, microdosing) and are prepared to request pricing for non-cash-published options.

Where PlexusDx fits

PlexusDx wins the month-to-month price war on semaglutide ($189 vs Eden's $198 and Found's $289) and matches Eden's tirzepatide MTM rate within $9 ($289 vs $298). The 6-month prepaid semaglutide plan (per-month figure of $149, $1,788 annual total) delivers the lowest 12-month cost in this comparison—$409 below Found's 12-month prepaid total and $588 below Eden's monthly-only total. If you're certain about a six-month commitment, PlexusDx's prepaid pricing beats both competitors. If you prefer oral GLP-1s or want a maintenance microdose protocol after initial weight loss, PlexusDx publishes transparent pricing for those formats while Eden and Found's cash-published options remain injectable-only. The single all-inclusive charge and calendar-month billing simplify budgeting compared to Eden's two-charge structure and Found's 13-cycle year.

Methodology and freshness

We captured Eden pricing and terms on September 1, 2026, verified against a July 19, 2026 snapshot. Found cash and insurance rates were captured September 1, 2026, verified against a July 20, 2026 snapshot. PlexusDx pricing was verified September 1, 2026. All 12-month cost calculations, prepaid per-month figures, and annual totals are our calculations using standard ongoing rates and prepaid totals only. Found's month-to-month cash plan bills every 4 weeks, producing 13 charges per year; Eden and PlexusDx bill calendar-monthly, producing 12 charges per year. Found's 12-month prepaid plan bills every 48 weeks; we calculated the annual total as 13 months × the per-month figure to reflect the billing cadence. Like-for-like comparisons pair month-to-month rates against month-to-month rates, and prepaid terms against prepaid terms of matching length. If you find conflicting figures at checkout, confirm the rate and billing cadence with the provider before purchasing.

Frequently Asked Questions

Does Eden's membership fee apply every month?

Yes. Eden's pricing structure splits each monthly charge into two components: the medication cost ($99 for semaglutide, $199 for tirzepatide) and a mandatory $99/month membership fee. Both charges recur monthly, producing $198 total for semaglutide and $298 total for tirzepatide. You cannot purchase the medication without the membership.

Why does Found's month-to-month plan cost more annually than PlexusDx or Eden?

Found bills month-to-month cash plans every 4 weeks instead of calendar-monthly, creating 13 billing cycles per year instead of 12. At $289 per cycle for semaglutide, you pay $3,757 annually (our calculation: 13 × $289) versus PlexusDx's $2,268 (12 × $189) or Eden's $2,376 (12 × $198). Found's 12-month prepaid plan drops the per-month figure to $169 but requires upfront payment every 48 weeks.

Can I use insurance with any of these providers?

Found accepts insurance for eligible members, advertising $99–$199/month depending on plan length, medication, and coverage; copays may apply, and Found reports being in-network for 1 in 3 Americans. Eden's captured sources do not mention insurance acceptance. PlexusDx does not accept insurance for medication but is HSA/FSA eligible. Confirm your coverage and out-of-pocket costs with each provider before enrolling.

Which provider offers the lowest total cost for a full year of semaglutide?

PlexusDx's 6-month prepaid semaglutide plan costs a per-month figure of $149, totaling $1,788 over 12 months (our calculation: 2 × $894). Found's 12-month prepaid cash plan totals $2,197 (our calculation: 13 × $169). Eden's monthly-only plan totals $2,376 (our calculation: 12 × $198). PlexusDx delivers the lowest annual cost if you commit to two 6-month cycles.

Do any of these providers offer oral GLP-1 capsules or microdose protocols?

PlexusDx publishes pricing for oral semaglutide ($289 MTM) and oral tirzepatide ($349 MTM), plus a microdose GLP-1 protocol ($129 MTM). Eden's captured sources list injectable formats only. Found's homepage mentions additional medications including microdosing, but no cash pricing was published for those options in our September 2026 capture; contact Found directly for quotes on non-injectable formats.

Sources

• Eden pricing and membership terms, eden.com, captured and verified September 1, 2026 and July 19, 2026
• Found cash-pay and insurance pricing, joinFound.com, captured and verified September 1, 2026 and July 20, 2026
• Found pricing detail page, joinFound.com/pricing, captured September 1, 2026
• PlexusDx product and pricing pages, plexusdx.com, verified September 1, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.